MARKET

CERS

CERS

Cerus
NASDAQ
1.850
+0.050
+2.78%
Closed 17:47 02/14 EST
OPEN
1.790
PREV CLOSE
1.800
HIGH
1.900
LOW
1.790
VOLUME
1.19M
TURNOVER
0
52 WEEK HIGH
2.585
52 WEEK LOW
1.375
MARKET CAP
343.57M
P/E (TTM)
-17.2093
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CERS last week (0210-0214)?
Weekly Report · 1d ago
Weekly Report: what happened at CERS last week (0203-0207)?
Weekly Report · 02/10 11:24
Press Release: Cerus Corporation to Release Fourth Quarter and Full-Year 2024 Financial Results on February 20, 2025
Dow Jones · 02/07 13:32
Cerus Director Gail Schulze to Step Down
TipRanks · 02/06 21:42
Weekly Report: what happened at CERS last week (0127-0131)?
Weekly Report · 02/03 11:29
Weekly Report: what happened at CERS last week (0120-0124)?
Weekly Report · 01/27 11:33
Top SA Quant-rated medical devices stocks as technicals look strong
Seeking Alpha · 01/22 16:44
Weekly Report: what happened at CERS last week (0113-0117)?
Weekly Report · 01/20 11:23
More
About CERS
Cerus Corporation is a biomedical products company. The Company is focused on developing and commercializing the INTERCEPT Blood System to enhance blood safety. The INTERCEPT Blood System, which is based on its proprietary technology for controlling biological replication, is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. Its INTERCEPT Blood System is intended for use with blood components and certain of their derivatives: platelets, plasma, red blood cells and to produce INTERCEPT Fibrinogen Complex (IFC), and pathogen reduced plasma, cryoprecipitate reduced. The INTERCEPT Blood System for Cryoprecipitation uses its plasma system to produce IFC for the treatment and control of bleeding, including massive hemorrhage, associated with fibrinogen deficiency. In addition, the INTERCEPT Blood System for Cryoprecipitation is used to produce pathogen reduced plasma, cryoprecipitate reduced.

Webull offers Cerus Corp stock information, including NASDAQ: CERS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CERS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CERS stock methods without spending real money on the virtual paper trading platform.